HER2/NEU NEGATIVE
Clinical trials for HER2/NEU NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU NEGATIVE trials appear
Sign up with your email to follow new studies for HER2/NEU NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo offers hope for frail elderly with breast cancer
Disease control CompletedThis study tested a two-drug combination (fulvestrant and palbociclib) to control breast cancer in patients aged 70 and older who could not undergo surgery due to frailty or who refused it. The goal was to see if this non-surgical approach could keep the cancer from growing for a…
Matched conditions: HER2/NEU NEGATIVE
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for Tough-to-Treat breast cancer: Two-Drug combo tested
Disease control CompletedThis study tested whether adding the hormone therapy fulvestrant to a new drug called alisertib works better than alisertib alone for women with advanced breast cancer that has spread and stopped responding to standard hormone treatments. It involved 96 postmenopausal women. Rese…
Matched conditions: HER2/NEU NEGATIVE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC